{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:27:03Z","timestamp":1792016823205,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T00:00:00Z","timestamp":1365465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2013.18","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T09:38:05Z","timestamp":1365500285000},"page":"e244-e244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["Alterations in metabolic pathways and networks in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"3","author":[{"given":"R","family":"Kaddurah-Daouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S G","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N O","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Motsinger-Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Q","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Pharmacometabolomics Research Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,9]]},"reference":[{"key":"BFtp201318_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O'Brien RJ, Wong PC . Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 2011; 34: 185\u2013204.","journal-title":"Annu Rev Neurosci"},{"key":"BFtp201318_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrn3012","volume":"12","author":"G Di Paolo","year":"2011","unstructured":"Di Paolo G, Kim TW . Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond. Nat Rev Neurosci 2011; 12: 284\u2013296.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201318_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G . Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012; 13: 263\u2013269.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFtp201318_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KR . Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009; 34: 173\u2013186.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201318_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1194\/jlr.M022376","volume":"53","author":"Y Sato","year":"2012","unstructured":"Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y . Identification of a new plasma biomarker of Alzheimer\u2019s disease using metabolomics technology. J Lipid Res 2012; 53: 567\u2013576.","journal-title":"J Lipid Res"},{"key":"BFtp201318_CR6","doi-asserted-by":"publisher","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR et al. Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 2011; 6: e21643.","journal-title":"PLoS One"},{"key":"BFtp201318_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette CM, Burke JR et al. Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement 2011; 7: 309\u2013317.","journal-title":"Alzheimers Dement"},{"key":"BFtp201318_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1371\/journal.pone.0031501","volume":"7","author":"C Czech","year":"2012","unstructured":"Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V et al. Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid. PLoS One 2012; 7: 16.","journal-title":"PLoS One"},{"key":"BFtp201318_CR9","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Oresic","year":"2011","unstructured":"Oresic M, Hyotylainen T, Herukka SK, Sysi-Aho M, Mattila I, Julkunen V et al. Metabolome in progression to Alzheimer\u2019s disease. Transl Psychiatry 2011; 1: e57.","journal-title":"Transl Psychiatry"},{"key":"BFtp201318_CR10","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1038\/tp.2011.22","volume":"1","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Boyle S, Matson W, Sharma S, Matson S, Zhu H et al. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry 2011; 1: e26.","journal-title":"Transl Psychiatry"},{"key":"BFtp201318_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BFtp201318_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56: 303\u2013308.","journal-title":"Arch Neurol."},{"key":"BFtp201318_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ymeth.2012.03.023","volume":"56","author":"JH Kang","year":"2012","unstructured":"Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM . Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer\u2019s disease. Methods 2012; 56: 484\u2013493.","journal-title":"Methods"},{"key":"BFtp201318_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1198\/jasa.2009.0126","volume":"104","author":"J Peng","year":"2009","unstructured":"Peng J, Wang P, Zhou N, Zhu J . Partial correlation estimation by joint sparse regression models. J Am Stat Assoc 2009; 104: 735\u2013746.","journal-title":"J Am Stat Assoc"},{"key":"BFtp201318_CR15","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1214\/009053606000000281","volume":"34","author":"N Meinshausen","year":"2006","unstructured":"Meinshausen N, B\u00fchlmann P . High dimensional graphs and variable selection with the Lasso. Ann Statist 2006; 34: 1436\u20131462.","journal-title":"Ann Statist"},{"key":"BFtp201318_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1742-1241.2009.02026.x","volume":"63","author":"T Vogel","year":"2009","unstructured":"Vogel T, Dali-Youcef N, Kaltenbach G, Andres E . Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 2009; 63: 1061\u20131067.","journal-title":"Int J Clin Pract"},{"key":"BFtp201318_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-2009-1187","volume":"18","author":"J Popp","year":"2009","unstructured":"Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, K\u00f6lsch H et al. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer\u2019s disease. J Alzheimers Dis 2009; 18: 819\u2013828.","journal-title":"J Alzheimers Dis"},{"key":"BFtp201318_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/BC.2009.033","volume":"390","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL . Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009; 390: 191\u2013214.","journal-title":"Biol Chem"},{"key":"BFtp201318_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/jnr.20394","volume":"79","author":"D Boyd-Kimball","year":"2002","unstructured":"Boyd-Kimball D, Sultana R, Abdul HM, Butterfield DA . Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer\u2019s disease. J Neurosci Res 2002; 79: 700\u2013706.","journal-title":"J Neurosci Res"},{"key":"BFtp201318_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.freeradbiomed.2012.01.012","volume":"52","author":"M Zampagni","year":"2012","unstructured":"Zampagni M, Wright D, Cascella R, D'Adamio G, Casamenti F, Evangelisti E et al. Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med 2012; 52: 1362\u20131371.","journal-title":"Free Radic Biol Med"},{"key":"BFtp201318_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.32.2.164","volume":"32","author":"W Bondareff","year":"1982","unstructured":"Bondareff W, Mountjoy CQ, Roth M . Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164\u2013168.","journal-title":"Neurology"},{"key":"BFtp201318_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2005.12.001","volume":"69","author":"E Shearman","year":"2006","unstructured":"Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N et al. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. Brain Res Bull 2006; 69: 204\u2013213.","journal-title":"Brain Res Bull"},{"key":"BFtp201318_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuint.2010.10.013","volume":"58","author":"B Gulyas","year":"2011","unstructured":"Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, V\u00e1rszegi S et al. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int 2011; 58: 60\u201368.","journal-title":"Neurochem Int"},{"key":"BFtp201318_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000082663","volume":"19","author":"PN Wang","year":"2005","unstructured":"Wang PN, Liu HC, Liu TY, Chu A, Hong CJ, Lin KN et al. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. Dement Geriatr Cogn Disord 2005; 19: 120\u2013125.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BFtp201318_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2202-10-125","volume":"10","author":"MF Martinez","year":"2009","unstructured":"Martinez MF, Martin XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI et al. The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers. BMC Neurosci 2009; 10: 125\u2013130.","journal-title":"BMC Neurosci"},{"key":"BFtp201318_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.neurobiolaging.2006.05.027","volume":"28","author":"B Borroni","year":"2007","unstructured":"Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S et al. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease. Neurobiol Aging 2007; 28: 1231\u20131238.","journal-title":"Neurobiol Aging"},{"key":"BFtp201318_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1582-4934.2010.01123.x","volume":"14","author":"ZT Kincses","year":"2010","unstructured":"Kincses ZT, Toldi J, Vecsei L . Kynurenines, neurodegeneration and Alzheimer\u2019s disease. J Cell Mol Med 2010; 14: 2045\u20132054.","journal-title":"J Cell Mol Med"},{"key":"BFtp201318_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","volume":"18","author":"JL Albasanz","year":"2008","unstructured":"Albasanz JL, Perez S, Barrachina M, Ferrer I, Martin M . Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease. Brain Pathol 2008; 18: 211\u2013219.","journal-title":"Brain Pathol"},{"key":"BFtp201318_CR29","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","volume":"286","author":"C Delarasse","year":"2011","unstructured":"Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM . The purinergic receptor P2 \u00d7 7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J Biol Chem 2011; 286: 2596\u20132606.","journal-title":"J Biol Chem"},{"key":"BFtp201318_CR30","doi-asserted-by":"publisher","first-page":"18696","DOI":"10.1074\/jbc.M500219200","volume":"280","author":"JM Camden","year":"2005","unstructured":"Camden JM, Schrader AM, Camden RE, Gonz\u00e1lez FA, Erb L, Seye CI et al. P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem 2005; 280: 18696\u201318702.","journal-title":"J Biol Chem"},{"key":"BFtp201318_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bmcl.2010.02.008","volume":"20","author":"A Rivkin","year":"2010","unstructured":"Rivkin A, Ahearn SP, Chichetti SM, Hamblett CL, Garcia Y, Martinez M et al. Purine derivatives as potent gamma-secretase modulators. Bioorg Med Chem Lett 2010; 20: 2279\u20132282.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFtp201318_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/JAD-2012-112138","volume":"31","author":"S Arlt","year":"2012","unstructured":"Arlt S, Schwedhelm E, Kolsch H, Jahn H, Linnebank M, Smulders Y et al. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer\u2019s disease. J Alzheimers Dis 2012; 31: 751\u2013758.","journal-title":"J Alzheimers Dis"},{"key":"BFtp201318_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000326301","volume":"65","author":"MA Smach","year":"2011","unstructured":"Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L et al. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer\u2019s disease or dementia: a case control study. Eur Neurol 2011; 65: 270\u2013278.","journal-title":"Eur Neurol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp201318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp201318","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:00:29Z","timestamp":1672938029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,9]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"alternative-id":["BFtp201318"],"URL":"https:\/\/doi.org\/10.1038\/tp.2013.18","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,9]]},"assertion":[{"value":"4 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Drs Kaddurah-Daouk and Matson are inventors on patents in the metabolomics field. Dr Kaddurah-Daouk has received funding from pharmaceutical companies for metabolomic studies. Dr Arnold has received research grant support through the University of Pennsylvania from the NIH, the American Health Assistance Foundation and the Marian S Ware Alzheimer\u2019s Program, as well as several pharmaceutical companies and advisory\/speaking honoraria from Universities, pharmaceutical companies and law firms. Dr Trojanowski may accrue revenue in the future on patents submitted by the University of Pennsylvania wherein he is co-inventor and he received revenue from the sale of Avid to Eli Lily as co-inventor on imaging-related patents submitted by the University of Pennsylvania while he receives research support from the NIH, Bristol Myer Squib, AstraZeneca and several non-profits. Dr Doraiswamy has received research grants (through Duke) and advisory\/speaking fees from the NIH, the Alzheimer\u2019s Association, the Alzheimer\u2019s Drug Discovery Foundation, the Alzheimer\u2019s Foundation of America, and several pharmaceutical companies; and he owns stock in Sonexa and Clarimedix. Dr Motsinger-Reif has received consulting honoraria from pharmaceutical companies. The remaining co-authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}